AR1001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AR1001, covering 2021-07-21 to 2025-10-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) [Phase 3]